[ad_1]
(HealthDay)—An increased risk for nonfatal drug-related poisoning is associated with benzodiazepine treatment in patients with opioid use disorder, according to a study published online March 3 in The American Journal of Psychiatry.
Kevin Y. Xu, M.D., from the Washington University School of Medicine in St. Louis, and colleagues used data from the IBM MarketScan database (2006 to 2016) to identify prescription claims in persons (aged 12 to 64 years) with opioid use disorder who were prescribed buprenorphine and who experienced drug-related poisoning.
The researchers found that buprenorphine treatment days were associated with a reduction in the risk for poisoning events (odds ratio [OR], 0.63) relative to nontreatment days. Benzodiazepine treatment days were associated with an increase in the risk for such events (OR, 1.88). There was an increase seen in poisonings associated with low-dose (OR, 1.78) and high-dose benzodiazepine treatment (OR, 2.22). High-dose benzodiazepine treatment was associated with increased poisonings in combination with buprenorphine cotreatment (OR, 1.64), but this was lower than the risk associated with benzodiazepine treatment in the absence of buprenorphine (ORs, 1.69 and 2.23 for low-dose and high-dose, respectively).
“Dose reduction of benzodiazepines while maintaining buprenorphine treatment may have the advantage of lowering drug-related poisoning risk,” the authors write.
Opioid overdose reduced in patients taking buprenorphine
Abstract/Full Text (subscription or payment may be required)
Copyright © 2021 HealthDay. All rights reserved.
Citation:
Benzodiazepines up risk for nonfatal drug-related poisoning in OUD (2021, April 2)
retrieved 3 April 2021
from https://medicalxpress.com/news/2021-04-benzodiazepines-nonfatal-drug-related-poisoning-oud.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
[ad_2]
Source link
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022
